MCEWAN ALASTAIR STUART 4
4 · CORNERSTONE THERAPEUTICS INC · Filed Jun 16, 2009
Insider Transaction Report
Form 4
MCEWAN ALASTAIR STUART
Director
Transactions
- Sale
Common Stock
2009-06-12$8.51/sh−3,388$28,832→ 51,457 total - Sale
Common Stock
2009-06-15$8.51/sh−43,316$368,619→ 8,141 total
Footnotes (2)
- [F1]The price reported in Column 5 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.50 to $8.60, inclusive. The reporting person undertakes to provide to Cornerstone Therapeutics Inc., any security holder of Cornerstone Therapeutics Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]The price reported in Column 5 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.50 to $9.00, inclusive. The reporting person undertakes to provide to Cornerstone Therapeutics Inc., any security holder of Cornerstone Therapeutics Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.